atai Life Sciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Rhea-AI Summary
atai Life Sciences (NASDAQ: ATAI), a clinical-stage biopharmaceutical company focused on mental health disorders, has announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference in New York, NY from September 9-11, 2024. The company's management team will engage in a fireside chat on Tuesday, September 10 at 4:30 P.M. EDT, along with 1x1 investor meetings.
Investors can access the fireside chat via a provided webcast link, and an archived replay will be available on the company's website for up to 90 days. This participation offers atai an opportunity to showcase its progress and strategies in transforming mental health treatment to a global investment audience.
Positive
- None.
Negative
- None.
NEW YORK and BERLIN, Sept. 04, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced that the Company’s management team is scheduled to participate in the H.C. Wainwright 26th Annual Global Investment Conference in New York, NY from September 9-11, 2024. Details of the company’s participation:
Format: Fireside chat and 1x1 investor meetings
Date and Time: Fireside chat on Tuesday, September 10 at 4:30 P.M. EDT
Webcast link: Here
An archived replay will be available on the Investors section of the atai website under Events for up to 90 days.
About atai Life Sciences
atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders and was founded as a response to the significant unmet need and lack of innovation in the mental health treatment landscape. atai is dedicated to efficiently developing innovative therapeutics to treat depression, anxiety, addiction, and other mental health disorders. By pooling resources and best practices, atai aims to responsibly accelerate the development of new medicines to achieve clinically meaningful and sustained behavioral change in mental health patients. atai's vision is to heal mental health disorders so that everyone, everywhere can live a more fulfilled life. For more information, please visit www.atai.life.
Contact Information
Investor Contact:
Media Contact:
FAQ
When is atai Life Sciences (ATAI) participating in the H.C. Wainwright Global Investment Conference?
What type of company is atai Life Sciences (ATAI)?
How can investors access atai Life Sciences' (ATAI) presentation at the H.C. Wainwright conference?
What is the format of atai Life Sciences' (ATAI) participation in the H.C. Wainwright conference?
